3rd Circ. Won't Revive Federal Claim On Pharma Accreditation

By P.J. D'Annunzio (May 19, 2022, 5:15 PM EDT) -- The Third Circuit on Thursday ruled that wholesale pharmaceutical distributors Oak Drugs Inc. and PriMed Pharmaceuticals LLC cannot sue a private entity for alleged federal due process violations stemming from delaying their industry accreditation, reasoning that constitutional claims are only applicable when a state actor is involved....

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!


Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!